Biogenic synthesis and cytotoxic effects of silver nanoparticles mediated by white rot fungi

G Krishna, V Srileka, MAS Charya, ESA Serea… - Heliyon, 2021 - cell.com
Silver nanoparticles (AgNPs) were successfully synthesized using silver nitrate via the
biological route using the culture filtrate of Ganoderma enigmaticum as well as Trametes …

Persistence of ctDNA in patients with breast cancer during neoadjuvant treatment is a significant predictor of poor tumor response

Q Zhou, SP Gampenrieder, S Frantal… - Clinical Cancer …, 2022 - AACR
Purpose: Accurate response assessment during neoadjuvant systemic treatment (NST)
poses a clinical challenge. Therefore, a minimally invasive assessment of tumor response …

Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score

S Robertson, B Acs, M Lippert, J Hartman - Breast cancer research and …, 2020 - Springer
Purpose The proliferation-associated biomarker Ki67 has potential utility in breast cancer,
including aiding decisions based on prognosis, but has unacceptable inter-and …

Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: when, why and what?

R Torrisi, E Marrazzo, E Agostinetto… - Critical Reviews in …, 2021 - Elsevier
Indication for neoadjuvant chemotherapy (NACT) in HR+/HER2-negative tumors is
controversial. Pathological complete response (pCR) rates range from 0 to 18% while breast …

[HTML][HTML] De-escalation of axillary irradiation for early breast cancer–Has the time come?

E Senkus, MJ Cardoso, O Kaidar-Person… - Cancer Treatment …, 2021 - Elsevier
Introduction of sentinel lymph node biopsy, initially in clinically node-negative and
subsequently in patients presenting with involved axilla and downstaged by primary …

Body mass index and tumor-infiltrating lymphocytes in triple-negative breast cancer

G Floris, F Richard, AS Hamy, L Jongen… - JNCI: Journal of the …, 2021 - academic.oup.com
Background High levels of stromal tumor-infiltrating lymphocytes (sTIL) are associated with
increased pathological complete response (pCR) rate and longer survival after neoadjuvant …

SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

F Ayala de la Peña, S Antolín Novoa… - Clinical and …, 2023 - Springer
Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is
rapidly increasing. Thanks to the screening programs in place, nearly 90% of breast cancer …

Systemic treatment of breast cancer. 1st central-eastern European professional consensus statement on breast cancer

G Rubovszky, J Kocsis, K Boér… - Pathology and …, 2022 - por-journal.com
This text is based on the recommendations accepted by the 4th Hungarian Consensus
Conference on Breast Cancer, modified based on the international consultation and …

Breast cancer surgery: new issues

F Magnoni, S Alessandrini, L Alberti, A Polizzi, A Rotili… - Current …, 2021 - mdpi.com
Since ancient times, breast cancer treatment has crucially relied on surgeons and clinicians
making great efforts to find increasingly conservative approaches to cure the tumor. In the …

Oncoplastic breast-conserving surgery for synchronous multicentric and multifocal tumors: is it oncologically safe? A retrospective matched-cohort analysis

F De Lorenzi, F Borelli, E Pagan, V Bagnardi… - Annals of Surgical …, 2022 - Springer
Background Oncoplastic surgery is a well-established approach that combines breast-
conserving treatment for breast cancer and plastic surgery techniques. Although this …